Chester County News and Community Website
EXTON, PA — Immunome, Inc. (Nasdaq: IMNM) recently announced updates to the ongoing development of its lead oncology program, IMM-ONC-01, a novel immuno-oncology agent that inhibits IL-38, an immunosuppressive cytokine.
Immunome Provides Research & Development Update on Lead Oncology Candidate Targeting IL-38 Read More
CHEYNEY, PA — Navrogen Inc. and Tavotek Biotherapeutics announced today that they have entered into a strategic collaboration to identify and develop experimental monoclonal antibodies (mAbs) for the treatment of …
Navrogen Inc. and Tavotek Biotherapeutics Announce Strategic Collaboration Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration has granted accelerated approval to Jemperli (dostarlimab) for treating patients with recurrent or advanced endometrial cancer that has progressed on or …
FDA Approves Immunotherapy for Endometrial Cancer with Specific Biomarker Read More